Hypotension Clinical Trial
— VASOSHOCKOfficial title:
Early Initiated Vasopressor Therapy vs. Standard Care of Primarily Fluid Therapy in Hypotensive Patients in the Emergency Department - A Pragmatic, Multi-center, Superiority, Randomized Controlled Trial
The goal of this pragmatic, multi-center, superiority, randomized clinical trial is to compare early treatment with peripheral (through a vein) infused noradrenaline (a natural hormone that increases blood pressure) with fluid only therapy in patients with hypotensive and shock in the Danish Emergency Departments (ED). The main questions it aims to answer are: If early initiated noradrenaline in non-bleeding hypotensive patients presenting in the ED can - Improve time to shock control. - Reduce the need for ICU admittance. - Decrease mortality. Participants will be included by the clinical staff and treated urgently with either noradrenaline or usual treatment during their Emergency Department stay. After completion of the treatment in the Emergency Department, patient data will be extracted from the bed-side measurements, electronic health records and national registers. Patients will be contacted by the research staff 1 year after study inclusion to answer brief questions about their daily physical function and ability to care for themselves. Researchers will compare with patients receiving fluid therapy only, as this is the usual standard of care in Danish Emergency Departments.
Status | Recruiting |
Enrollment | 320 |
Est. completion date | January 31, 2026 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - At least 18 years of age - Signs or suspicion of hypotension or shock (of any type such as septic, vasodilatory or hypovolemic not included in the exclusion criteria) defined as: 1. SBP < 100mmHg or MAP < 65 mmHg combined with lactate > 2.0 mmol/L, 2. Physician defined blood pressure for the individual patient combined with a lactate > 2.0 mmol/L 3. Either SBP < 100mmHg or MAP < 65mmHg with obvious signs of shock with any lactate level evaluated by either two non-specialist physicians (e.g. registrar medical doctors) or a specialist physician. - Received at least 500ml of intravenous fluid before study inclusion (Including prehospital administration) within the first 4 hours of ED arrival. - Clinical Frailty Score (CFS) of =4. If CFS is =5 and the treating physician find the patient suitable for ICU admittance, the participant can be enrolled, if the on-call ICU doctor would accept the patient for ICU admittance. If the treating physician is unsure of ICU eligibility, regardless of CFS score, the patient should be consulted with the ICU consultant before study inclusion. Exclusion Criteria: - Cardiogenic, anaphylactic, haemorrhagic, or neurogenic shock suspected by the treating physician. - Fertile women (<60 years of age) with positive urine human gonadotropin (hCG) or plasma-hCG or women breastfeeding. - Patient deemed terminally ill or with a severe co-morbid status resulting in non-eligibility for ICU admittance decided by either the treating physician or ICU consultant. - Known allergy to noradrenaline. |
Country | Name | City | State |
---|---|---|---|
Denmark | Bispebjerg Hospital | Copenhagen | |
Denmark | Esbjerg Hospital | Esbjerg | |
Denmark | Gødstrup Regional Hospital | Herning | |
Denmark | Zealand University Hospital | Køge | |
Denmark | Odense University Hospital | Odense |
Lead Sponsor | Collaborator |
---|---|
Odense University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Proportion of patients receiving vasopressor at any point within 24 hours | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 24 hours | |
Other | Time to vasopressor initiation | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 30 days | |
Other | Hours of vasopressor infusion | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 30 days | |
Other | Proportion of patients with pulmonary oedema within 72 hours | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 72 hours | |
Other | Proportion of patients with acute kidney failure within 72 hours | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 72 hours | |
Other | Proportion of patients admitted to the ICU | Data is extracted from the patient's electronic medical records. | At 30 days | |
Other | ED Length of stay | Data is extracted from the patient's electronic medical records. | At 72 hours | |
Other | ICU length of stay | Data is extracted from the patient's electronic medical records. | At 30 days | |
Other | Hospital length of stay | Data is extracted from the patient's electronic medical records. | At 30 days | |
Other | Proportion and duration of mechanical ventilation | Data is extracted from the patient's electronic medical records. | At 30 days | |
Other | Proportion and length of renal replacement therapy | Data is extracted from the patient's electronic medical records. | At 30 days | |
Other | Amount of fluid therapy within the first 24 hours | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 24 hours | |
Other | Proportion of serious adverse events for noradrenaline or fluid therapy, e.g. extravasation or overdosis of noradrenaline, pulmonary edema, new cardiac arrhytmias, during the intervention of control period | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 24 hours | |
Primary | The primary outcome is the proportion of patients achieving either SBP >100 mmHg or MAP > 65 mmHg or a target blood pressure set by the treating physician at 90 (±15) minutes after inclusion. | Bed-side assessment during treatment and registered in the case report form. | At 90 minutes | |
Secondary | Number of intensive care unit (ICU) free days alive within 30 days | Data is extracted from the Danish national registries or the patient's electronic medical record. | At 30 days | |
Secondary | Time without shock within 24 hours | Bed-side assessment during treatment and registered in the case report form or by extraction from the patient's electronic medical record. | At 24 hours | |
Secondary | 30-day all-cause mortality | Data is extracted from the Danish national registries or the patient's electronic medical records. | At 30 days | |
Secondary | In-hospital all-cause mortality | Data is extracted from the Danish national registries or the patient's electronic medical records. | At hospital discharge, an average of 30 days efter inclusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Active, not recruiting |
NCT02016599 -
Effects of Transitional Circulation in ELBW Infants
|
||
Recruiting |
NCT05836610 -
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
|
Phase 4 | |
Completed |
NCT03215797 -
Phenylephrine or Norepinephrine for a Better Hemodynamic Stability
|
Phase 3 | |
Completed |
NCT02907931 -
Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status
|
N/A | |
Suspended |
NCT02315937 -
Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography'
|
N/A | |
Recruiting |
NCT02532270 -
Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring
|
N/A | |
Completed |
NCT02437799 -
Dicrotic Notch and Hypotension at Caesarean Under Spinal Anaesthesia
|
N/A | |
Completed |
NCT02802683 -
Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery
|
Phase 4 | |
Not yet recruiting |
NCT01941472 -
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous pO2 Variations to Predict Fluid Responsiveness
|
N/A | |
Completed |
NCT01930227 -
Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hypotension After Spinal Anesthesia in Parturients
|
N/A | |
Completed |
NCT02146898 -
The Severity Of Hypotension Comparing Three Positions During Spinal Anesthesia For Cesarean Delivery
|
N/A | |
Recruiting |
NCT01434251 -
Treatment of Hypotension of Prematurity (TOHOP)
|
N/A | |
Completed |
NCT01592669 -
Passive Leg Raising Attenuates and Delays Tourniquet Deflation-induced Hypotension and Tachycardia
|
N/A | |
Withdrawn |
NCT01183741 -
Accuracy of Non-Invasive Blood Pressure Measurement in Adults
|
Phase 3 | |
Completed |
NCT00991627 -
Different Approaches to Maternal Hypotension During Cesarean Section
|
Phase 4 | |
Withdrawn |
NCT00750516 -
Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet
|
||
Completed |
NCT00115726 -
Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure
|
Phase 4 | |
Recruiting |
NCT05513066 -
Management Arterial Hypotension During Planned Caesarean Section, Intravenous Ephedrine/Phenylephrine Mixture Versus Intravenous Baby Noradrenaline
|
||
Completed |
NCT04089644 -
Manual vs Closed-loop Control of Mean Arterial Pressure
|
N/A |